Literature DB >> 6146517

Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.

C B Srikant, Y C Patel.   

Abstract

Cysteamine (CSH) administered as a single sc injection to rats produced rapid depletion of cerebrocortical Somatostatin-14 like immunoreactivity (S-14 LI) with a significant 48% reduction occurring within 5 min and maximum (72%) decrease at 4 h. The depletion of S-14 LI was associated with a 1.7 fold increase in Bmax of the cerebrocortical S-14 receptors 5 min after CSH administration and a concomitant but slower increase in the affinity of these receptors [dissociation constant (Kd) being 1.8- and 1.6-fold lower than the control at 30 and 60 min, respectively, post CSH]. Incubation of intact synaptosomes with 1 mM CSH at 37 C in vitro for 60 min also caused a rapid depletion of S-14 LI, but in contrast to the in vivo data, there was no change in the Bmax or Kd of the S-14 receptors for up to 30 min beyond which time a 2.8-fold decrease in the affinity of S-14 receptors was observed. Higher concentrations of CSH (greater than or equal to 10 mM) added during the incubation of synaptosomes in vitro completely abolished the specific binding of these receptors. The pituitary S-14 receptors were studied 30 min after CSH administration and unlike the cerebrocortical S-14 receptors at this time did not exhibit any change in Bmax or affinity. When added at the time of the binding assay CSH (1 mM) was without a direct effect on cerebrocortical as well as pituitary membrane S-14 receptors. Furthermore, addition of CSH at the time of binding assay did not destroy the integrity of [125I-Tyr11]S-14. It is concluded that administration of CSH to rats in vivo depletes brain S-14 LI and up-regulates synaptosomal S-14 receptors. Exposure of synaptosomes to CSH in vitro for 30 min also depletes S-14 LI but has no effect on S-14 receptors suggesting that S-14 receptor regulation by S-14 is an in vivo phenomenon or requires the intact cell. CSH has a direct inhibitory effect on S-14 receptor binding after prolonged in vitro incubation. Pituitary S-14 receptors unlike those in the brain are unaffected by S-14 LI depletion at least acutely.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146517     DOI: 10.1210/endo-115-3-990

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Developmental and regional alteration of kappa-opioid receptors in seizure-susceptible EL mouse brain.

Authors:  T Kai; H Onishi; S Koide; M Katayama; S Yamagami
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

2.  Naloxone or vagotomy does not influence centrally octreotide-induced inhibition of gastric acid secretion in rats.

Authors:  Feng Gao; Xiufen Hu; Dongsheng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

3.  Alteration of opioid receptors in seizure-susceptible El mouse brain.

Authors:  H Onishi; T Soma; S Yamagami; Y Kawakita
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

4.  Reduced somatostatin in hypothalamus of young male mouse increases local but not circulatory GH.

Authors:  Linlin Hao; Mingtang Li; Jianwei Dai; Qiong Wu; Yupeng Liu; Songcai Liu; Yongliang Zhang
Journal:  Neurochem Res       Date:  2010-01       Impact factor: 3.996

5.  Developmental and regional alteration of methionine enkephalin-like immunoreactivity in seizure-susceptible E1 mouse brain.

Authors:  H Onishi; S Koide; S Yamagami; Y Kawakita
Journal:  Neurochem Res       Date:  1990-01       Impact factor: 3.996

6.  Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. Evidence that intracellular somatostatin deficiency augments insulin and glucagon secretion.

Authors:  Y C Patel; I Pierzchala; M Amherdt; L Orci
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

7.  Decreased hypothalamic growth hormone-releasing hormone content and pituitary responsiveness in hypothyroidism.

Authors:  H Katakami; T R Downs; L A Frohman
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

8.  Somatostatin contributes to long-term potentiation at excitatory synapses onto hippocampal somatostatinergic interneurons.

Authors:  Anne-Sophie Racine; François-Xavier Michon; Isabel Laplante; Jean-Claude Lacaille
Journal:  Mol Brain       Date:  2021-08-24       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.